These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32983144)

  • 1. Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Buxbaum NP; Pavletic SZ
    Front Immunol; 2020; 11():2017. PubMed ID: 32983144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature.
    Neunert CE; Despotovic JM
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27569. PubMed ID: 30537439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
    Slavin S; Nagler A; Varadi G; Or R
    Exp Hematol; 2000 Jul; 28(7):853-7. PubMed ID: 10907647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.
    Page KM; Mendizabal AM; Prasad VK; Martin PL; Parikh S; Wood S; Sempowski GD; Szabolcs P; Kurtzberg J
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1108-1117. PubMed ID: 18804040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study.
    Mrazek F; Schneiderova P; Kriegova E; Raida L; Kuba A; Gajdos P; Königova N; Onderkova J; Ambruzova Z
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):55-61. PubMed ID: 28083617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.
    Marmont AM; Gualandi F; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 2003 Mar; 31(5):399-402. PubMed ID: 12634732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
    Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.
    Koo J; Giller RH; Quinones R; McKinney CM; Verneris MR; Knight-Perry J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28591. PubMed ID: 32658382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.
    Michniacki TF; Ebens CL; Choi SW
    Curr Oncol Rep; 2019 Aug; 21(10):87. PubMed ID: 31414187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-myeloablative transplants for malignant disease.
    Storb RF; Champlin R; Riddell SR; Murata M; Bryant S; Warren EH
    Hematology Am Soc Hematol Educ Program; 2001; ():375-91. PubMed ID: 11722994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in allotransplant immunology.
    Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N
    Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-hematopoietic stem cell transplantion immune-mediated cytopenias.
    Tsirigotis PD; Resnick IB; Or R; Elad S; Zilberman I; Yoffe L; Levovic A; Miron S; Gesundheit B; Slavin S; Shapira MY
    Immunotherapy; 2009 Jan; 1(1):39-47. PubMed ID: 20635972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children.
    Szanto CL; Langenhorst J; de Koning C; Nierkens S; Bierings M; Huitema ADR; Lindemans CA; Boelens JJ
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):114-122. PubMed ID: 31344451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
    Lv W; Qu H; Wu M; Fan Z; Huang F; Xu N; Xuan L; Lin R; Zhao K; Sun J; Lai Y; Xu Y; Liu Q
    Cancer Med; 2019 Nov; 8(15):6549-6558. PubMed ID: 31502764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.
    Hinterberger W; Hinterberger-Fischer M; Marmont A
    Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.